Dr. Bright Yaw Vigbedor is a Senior Lecturer at the School of Basic and Biomedical Sciences of the University of Health and Allied Sciences. He is a Pharmaceutical/Organic chemist by training. He also has expertise in Medicinal chemistry, diplomacy and international relations.
EDUCATION
He has BSc, M.Phil degree in Pharmaceutical chemistry and a PhD (Organic and Natural Products) from the Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. His PhD research project was on the ‘’Antimalarial activities of selected ethnopharmacological plants and structure elucidation of the active compounds’’. He also holds postgraduate Certificate (International Relations and Diplomacy) from the Graduate School of Governance and Leadership, Ghana and another online postgraduate certificate (Medicinal chemistry) from the EDX College, USA.
WORK EXPERIENCE
Dr. Vigbedor currently teaches and researches into Organic synthesis, spectroscopy, Natural products and Medicinal/pharmaceutical chemistry, Analytical biochemistry, Biological chemistry, Protein and Nucleic acid (RNA, DNA) chemistry at the University of Health and Allied Sciences. Before joining the University, he was a Graduate Assistant and Demonstrator at KNUST during his PhD program. He has extensive research experience from the Noguchi Memorial Institute for Medical Research, Tema General Hospital and the Centre for Plant Medicine Research etc.
SCIENCE /RESEARCH OUTPUT
Dr. Vigbedor has research interest in projects ranging from the isolation of bioactive compounds from plants (with application as antimalarial, anticancer, antisickling, antioxidant, antimicrobial and antiviral(HIV)), drug design and development (lead discovery, structural activity relationship studies and optimizations), design and validation of analytical methods, chromatography and isolation bioactive compounds from plants, spectroscopy and structural elucidation, quality control and assurance consultancy, organic synthesis/medicinal chemistry, product design and development etc. He is currently working on the isolation, design and synthesis of drug candidates for the treatment of drug resistant Plasmodium falciparum strains, antiviral (SARSCOV-2), antimicrobial, anticancer and sickle cell.
He has several publications in peer reviewed journals spanning from ethnopharmacological surveys, design and validation of analytical methods, in- vitro and in- vivo antimalarial activity and isolation of bioactive compounds from plants.